Clinical Ophthalmology (Sep 2020)
Comparative AAPOS Validation of the blinq. Birefringent Amblyopia Screener with Isolated Small-Angle Strabismus [Response to Letter]
Abstract
Robert W Arnold Pediatric Ophthalmology and Strabismus, Alaska Children’s EYE & Strabismus, Anchorage, Alaska 99508, USACorrespondence: Robert W ArnoldPediatric Ophthalmology and Strabismus, Alaska Children’s EYE & Strabismus, 3500 Latouche #280, Anchorage, Alaska 99508, USATel +1 (907)561-1917Fax +1 (907)563-5373Email [email protected] Since I was first introduced to the amazing concept of bilateral birefringent screening championed by David G Hunter and David Guyton decades ago, I have been longing to try the technology on my patients so I purchased the blinq.™ device as soon as it became commercially available in late 2019. View the original paper by Arnold This is in response to the Letter to the Editor